Though SE was the most effective therapy for Bowen disease, the risk for recurrence with 5-FU and MAL-PDT was negligible.

Health care providers can take steps to protect patients targeted by ICE, ensuring that patients retain their privacy and ...

In patients experiencing refractory ischemic digital complications from systemic sclerosis or other diseases, BTX injections are safe and effective.

The FDA grants Fast Track designation to sonelokimab for moderate to severe palmoplantar pustulosis, a chronic inflammatory skin disease.

Apremilast for 32 weeks significantly improves the signs and symptoms of moderate to severe genital psoriasis with a consistent safety profile.

South Texas Family Residential Center has confirmed 2 cases of measles among the 11000 adults and children detained there.

The FDA has granted Breakthrough Therapy designation for litifilimab for the treatment of cutaneous lupus erythematosus, a chronic autoimmune skin disease.

The 2025 to 2026 season has had an unusually highest rate of influenza hospitalizations and deaths among children.

Patients with early-onset KC are at an increased risk of developing other early-onset primary cancers when compared with control patients.

HealthDay News — For patients with desmoplastic melanoma, neoadjuvant treatment with pembrolizumab, a programmed death-1 (PD-1) immune checkpoint inhibitor, results in a pathological complete response ...

Life expectancy in the US increased from 2023 to 2024 while death rates and age-adjusted drug overdose rates decreased.

Trump proposed sending money directly to Americans among other ideas in response to the end of Obamacare subsidies.